DONQ-52

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameDONQ-52
Drug Alias NameDONQ-52
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionHLA class II histocompatibility antigen, DQ alpha 2 chain inhibitors
TargetsHLA class II histocompatibility antigen, DQ alpha 2 chain
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A